Diagnosis and topical therapy of lichen ruber planus in women


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The term lichen ruber planus (LRP) is understood as a chronic inflammatory disease of the skin and mucous membranes, including the genitals, which is caused by CD8+ cytotoxic T lymphocytes. Despite the fact that the dermatosis was described more than 100 years ago, the exact causes of its development have not been identified to date. There is an increase in the number of cases of genital LRP concurrent with lichen sclerosus, focal neurodermatitis, atrophic vulvovaginitis, genitourinary syndrome, vulvar candidiasis, desquamative vaginitis, herpetic and papillomavirus infections. The review summarizes an update on the dinical presentations of genital LRP, diagnosis, treatment approaches, drug dosage regimens, and its duration. Taking into account the fact that the pathogenesis of LRP is based on the formation of an inflammatory infiltrate, topical glucocorticosteroids are the drugs of choice for the treatment of LRP in the anogenital area. Conclusion: Genital LRP is a disease associated with a large number of causes and precipitating factors. Numerous studies have shown the efficiency of topical glucocorticosteroid therapy in combination with moisturizing and emollient agents. When properly administered and used, current topical corticosteroids are safe for patients with genital LRP.

Full Text

Restricted Access

About the authors

Nadezhda I. Chernova

Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology

Email: d.chernova@mail.ru
Dr. Med. Sci

Elena M. Maiorova

Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology

Email: eml20@mail.ru

Natalya I. Tapilskaya

St. Petersburg State Pediatric Medical University, Ministry of Health of Russia

Email: tapnatalia@yandex.ru
Dr. Med. Sci., Professor, Professor at the Department of Obstetrics and Gynecology

Daria B. Novikova

A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia

Email: dari07@bk.ru
Resident at the Department of Dermatology and Venereology

Aminat Ya. Atabieva

Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology

Email: amina-9308@mail.ru
Junior Researcher

References

  1. Goncalves D.L.M., Romero R.L., Ferreira P.L., Santi C.G. Clinical and epidemiological profile of patients attended in a vulvar clinic of the dermatology outpatient unit of a tertiary hospital during a 4-year period. Int. J. Dermatol. 2019; 58(11): 1311-6. https://dx.doi/org/10.1111/ijd.14442.
  2. Goldstein A., Metz A. Vulvar lichen planus. Clin. Obstet. Gynecol. 2005; 48(4): 818-23. https://dx.doi/org/10.1097/01.grf.0000179670.98939.b7.
  3. Day T., Moore S., Bohl T.G., Scurry J. Comorbid vulvar lichen planus and lichen sclerosus. J. Low. Genit. Tract Dis. 2017; 21(3): 204-8. https://dx.doi/org/10.1097/LGT.0000000000000307.
  4. van der Meijden W.I., Boffa M.J., Ter Harmsel B., Kirtschig G., Lewis F., Moyal-Barracco M. et al. 2021 European guideline for the management of vulval conditions. J. Eur. Acad. Dermatol. Venereol. 2022; 36(7): 952-72. https://dx.doi/org/10.1111/jdv.18102.
  5. Chew A., Stefanato C., Savarese I., Neill S.M., Fenton D.A., Lewis F.M. Clinical patterns of lichen planopilaris in patients with vulval lichen planus. Br. J. Dermatol. 2014; 170(1): 218-20. https://dx.doi/org/10.1111/bjd.12609.
  6. Day T., Weigner J., Scurry J. Classic and hypertrophic vulvar lichen planus. J. Low. Genit. Tract Dis. 2018; 22(4): 387-95. https://dx.doi/org/10.1097/LGT.0000000000000419.
  7. Gorouhi F., Davari P., Fazel N. Cutaneous and mucosal lichen planus: a comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Scientific World Journal. 2014; 2014: 742826. https://dx.doi/org/10.1155/2014/742826.
  8. Moyal-Barracco M., Edwards L. Diagnosis and therapy of anogenital lichen planus. Dermatol. Ther. 2004; 17(1): 38-46. https://dx.doi/org/10.1111/j.1396-0296.2004.04005.x.
  9. Simpson R.C., Littlewood S.M., Cooper S.M., Cruickshank M.E., Green C.M., Derrick E. et al. Reallife experience of managing vulval erosive lichen planus: a casebased review and UK multicentre case note audit. Br. J. Dermatol. 2012; 167(1): 85-91. https://dx.doi/org/10.1111/j.1365-2133.2012.10919.x.
  10. Cooper S.M., Wojnarowska F. Influence of treatment of erosive lichen planus of the vulva on its prognosis. Arch. Dermatol. 2006; 142(3): 289-94. https://dx.doi/org/10.1001/archderm.142.3.289.
  11. Danielsson K., Coates P.J., Ebrahimi M., Nylander E., Wahlin Y.B., Nylander K. Genes involved in epithelial differentiation and development are differentially expressed in oral and genital lichen planus epithelium compared to normal epithelium. Acta Derm. Venereol. 2014; 94(5): 526-30. https://dx.doi/org/10.2340/00015555-1803.
  12. Cooper S.M., Dean D., Allen J., Kirtschig G., Wojnarowska F. Erosive lichen planus of the vulva: weak circulating basement membrane zone antibodies are present. Clin. Exp. Dermatol. 2005; 30(5): 551-6. https://dx.doi/org/10.1111/j.1365-2230.2005.01866.x.
  13. Moutasim K.A., Poate T.W., Setterfteld J.F., Challacombe S.J. A case of vulvovaginal gingival lichen planus in association with Good’s syndrome. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2008; 105(3): e57-60. https://dx.doi/org/10.1016/j.tripleo.2007.09.029.
  14. Olszewska M., Banka-Wrona A., Skrok A., Rakowska A., Gorska R., Solomon L.W. et al. Vulvovaginal-gingival lichen planus: association with lichen planopilaris and stratified epithelium-specific antinuclear antibodies. Acta Derm. Venereol. 2016; 96(1): 92-6. https://dx.doi/org/10.2340/00015555-2141.
  15. Общероссийская общественная организация «Российское общество дерматовенерологов и косметологов». Клинические рекомендации. Лишай красный плоский. 2020.
  16. Day T., Wilkinson E., Rowan D., Scurry J. ISSVD Difficult Pathologic Diagnoses Committee (2020). Clinicopathologic diagnostic criteria for vulvar lichen planus. J. Low. Genit. Tract Dis. 2020; 24(3): 317-39. https://dx.doi/org/10.1097/LGT.0000000000000532.
  17. Borghi A., Corazza M., Minghetti S., Virgilli A. Preliminary study on dermoscopic features of vulvar lichen planus: newinsights for diagnosis. J. Eur. Acad. Dermatol. Venereol. 2016; 30(6): 1063-5. https://dx.doi/org/10.1111/jdv.13112.
  18. Bradford J., Fischer G. Management of vulvovaginal lichen planus: a new approach. J. Low. Genit. Tract Dis. 2013; 17(1): 28-32. https://dx.doi/org/10.1097/LGT.0b013e318258bf5b.
  19. Carbone M., Arduino P.G., Carrozzo M., Caiazzo G., Broccoletti R., Conrotto D. et al. Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J. Oral Pathol. Med. 2009; 38(2): 227-33. https://dx.doi/org/10.1111/j.1600-0714.2008.00688.x
  20. Чернова Н.И., Арутюнян Э. Современные аспекты терапии пациенток с дистрофией и атрофией интимной зоны. Что нового? Российский вестник акушера-гинеколога. 2018; 18(3): 95 8. https://dx.doi.org/10.17116/rosakush201818295-98.
  21. Charman C.R., Morris A.D., Williams H.C. Topical corticosteroid phobia in patients with atopic eczema. Br. J. Dermatol. 2000; 142(5): 931-6. 10.1046/j.1365-2133.2000.03473.x.
  22. Aubert-Wastiaux H., Moret L., Le Rhun A., Fontenoy A.M., Nguyen J.M., Leux C. et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br. J. Dermatol. 2011; 165(4): 808-14. https://dx.doi/org/10.1111/j.1365-2133.2011.10449.x.
  23. Дворянкова Е.В. Аногенитальные формы красного плоского лишая. Клиническая дерматология и венерология. 2019; 18(6): 762-7. https://doi.org/10.17116/klinderma201918061762.
  24. Byrd J.A., Davis M.D., Rogers R.D. Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. Arch. Dermatol. 2004; 140(6): 715-20. https://dx.doi.org/10.1001/archderm.140.6.715.
  25. Cline A., Cuellar-Barboza A., Jorizzo J.L., Pichardo R.O. Methotrexate for the treatment of recalcitrant erosive lichen planus of the vulva. JAMA Dermatol. 2020; 156(2): 215-7. https://dx.doi.org/10.1001/jamadermatol.2019.4062.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies